Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis

被引：0
|
作者：
Yoshikazu Ogawa
Nobunori Takahashi
Atsushi Kaneko
Yuji Hirano
Yasuhide Kanayama
Yuichiro Yabe
Takeshi Oguchi
Takayoshi Fujibayashi
Hideki Takagi
Masahiro Hanabayashi
Koji Funahashi
Masatoshi Hayashi
Seiji Tsuboi
Shuji Asai
Nobuyuki Asai
Takuya Matsumoto
Yasumori Sobue
Naoki Ishiguro
Toshihisa Kojima
机构：
[1] Nakatsugawa Municipal General Hospital,Department of Orthopaedic Surgery
[2] Nagoya University Graduate School of Medicine,Department of Orthopaedic Surgery
[3] Nagoya Medical Center,Department of Orthopedic Surgery and Rheumatology
[4] Toyohashi Municipal Hospital,Department of Rheumatology
[5] Toyota Kosei Hospital,Department of Orthopedic Surgery
[6] Tokyo Shinjuku Medical Center,Department of Rheumatology
[7] Anjo Kosei Hospital,Department of Orthopedic Surgery
[8] Konan Kosei Hospital,Department of Orthopedic Surgery
[9] Nagoya Central Hospital,Department of Orthopedic Surgery
[10] Ichinomiya Municipal Hospital,Department of Orthopedic Surgery
[11] Kariya–Toyota General Hospital,Department of Orthopedic Surgery
[12] Nagano Red Cross Hospital,Department of Rheumatology
[13] Shizuoka Kosei Hospital,Department of Orthopedic Surgery
来源：
Clinical Rheumatology | 2019年 / 38卷
关键词：
Biological therapy; Rheumatoid factor; Tumor necrosis factor; Survival analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2757 / 2763
页数：6
相关论文
共 50 条
  • [31] Effects of tumor necrosis factor-α inhibitors on lung lesions with rheumatoid arthritis
    Inoue, KI
    Takano, H
    Yanagisawa, R
    Yoshikawa, T
    CHEST, 2003, 124 (01) : 413 - 414
  • [32] The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Victoria Hernandez, Maria
    Sanmarti, Raimon
    Canete, Juan D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 613 - 624
  • [33] Predictors of tumor necrosis factor inhibitors primary failure in rheumatoid arthritis patients
    Khafagi, Amira Mohamed
    Mosa, Doaa Mosad
    Hawaas, Salah
    Hafez, Eman Abdelrazek
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
  • [34] ADHERENCE EVALUATIONS FOR TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR RHEUMATOID ARTHRITIS I
    Watanabe, J. H.
    Saseen, J. J.
    Dilokthomsakul, P.
    Campbell, J. D.
    VALUE IN HEALTH, 2017, 20 (05) : A148 - A148
  • [35] Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
    Emery, Paul
    Vlahos, Bonnie
    Szczypa, Piotr
    Thakur, Mazhar
    Jones, Heather E.
    Woolcott, John
    Estrella, Paul V. Santos
    Rolland, Catherine
    Gibofsky, Allan
    Citera, Gustavo
    Sockalingam, Sargunan
    Marshall, Lisa
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (04) : 493 - 501
  • [36] Validation of a bioassay for predicting response to tumor necrosis factor inhibitors in rheumatoid arthritis
    Ho, Ching-Huang
    Silva, Andrea A.
    Giles, Jon T.
    Bathon, Joan M.
    Solomon, Daniel H.
    Liao, Katherine P.
    Ho, I-Cheng
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (06) : 1086 - 1087
  • [37] Monoamine oxidase inhibitors in rheumatoid arthritis - anti-tumor necrosis factor?
    Altschuler, EL
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 2000, 22 (11): : 1007 - 1008
  • [38] Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis
    Fisher, Anat
    Bassett, Ken
    Goel, Gautam
    Stanely, Dana
    Brookhart, M. Alan
    Freeman, Hugh R.
    Wright, James M.
    Dormuth, Colin R.
    PLOS ONE, 2016, 11 (12):
  • [39] Comparative Effectiveness of Tocilizumab Monotherapy with Tumor Necrosis Factor Inhibitors in Combination with Methotrexate in Patients with Rheumatoid Arthritis and Prior Exposure to Tumor Necrosis Factor Inhibitors
    Harrold, Leslie R.
    Reed, George W.
    Best, Jennie
    Zlotnick, Steve
    Persuitte, Gioia
    Kremer, Joel M.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [40] Tumor necrosis factor inhibitors in psoriatic arthritis
    Mantravadi, Santhi
    Ogdie, Alexis
    Kraft, Walter K.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 899 - 910
12345